Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection

References

• BucherHGuyattGGriffithLWalterSThe results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trialsJ Clin Epidemiol19975066836919250266
   PubMed Web of Science ®Google Scholar
• SuttonAAdesACooperNAbramsKUse of indirect and mixed treatment comparisons for technology assessmentPharmacoeconomics200826975376718767896
   PubMed Web of Science ®Google Scholar
• WellsGSultanSChenLKhanMCoyleDIndirect Evidence: Indirect Treatment Comparisons In Meta-AnalysisOttawa, OntarioCanadian Agency for Drugs and Technologies in Health2009
   Google Scholar
• FuRGartlehnerGGrantMConducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care ProgramJ Clin Epidemiol201164111187119721477993
   PubMed Web of Science ®Google Scholar
• HoaglinDHawkinsNJansenJConducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2Value Health201114442943721669367
   PubMed Web of Science ®Google Scholar
• JansenJFleurenceRDevineBInterpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1Value Health201114441742821669366
   PubMed Web of Science ®Google Scholar
• DiasSWeltonNSuttonAAdesANICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials2011 Available from: http://www.nicedsu.org.uk/TSD2%20General%20meta%20analysis%20corrected%20Mar2013pdfAccessed February 12, 2013
   Google Scholar
• LiberatiAAltmanDTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaborationAnn Intern Med20091514W65W9419622512
   PubMed Web of Science ®Google Scholar
• LuGAdesACombination of direct and indirect evidence in mixed treatment comparisonsStat Med200423203105312415449338
   PubMed Web of Science ®Google Scholar
• ThorlundKDruytsEAvina-ZubietaJWuPMillsEWhy the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomingsAnn Rheum Dis Epub10202012
   Google Scholar
• JadadACookDBrowmanGA guide to interpreting discordant systematic reviewsCan Med Assoc J199715610141114169164400
   PubMed Web of Science ®Google Scholar
• McHutchisonJEversonGGordonSPROVE1 Study TeamTelaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infectionN Engl J Med20093601827183819403902
   PubMed Web of Science ®Google Scholar
• HezodeCForestierNDusheikoGPROVE2 Study TeamTelaprevir and peginterferon with or without ribavirin for chronic HCV infectionN Engl J Med20093601839185019403903
   PubMed Web of Science ®Google Scholar
• JacobsonIMcHutchisonJDusheikoGADVANCE Study TeamTelaprevir for previously untreated chronic hepatitis C virus infectionN Engl J Med20113642405241621696307
   PubMed Web of Science ®Google Scholar
• McHutchisonJMannsMMuirAPROVE3 Study TeamTelaprevir for previously treated chronic HCV infectionN Engl J Med20103621292130320375406
   PubMed Web of Science ®Google Scholar
• ZeuzemSAndreonePPolSREALIZE Study TeamTelaprevir for retreatment of HCV infectionN Engl J Med20113642417242821696308
   PubMed Web of Science ®Google Scholar
• KwoPLawitzEMcConeJSPRINT-1 InvestigatorsEfficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trialLancet201037670571620692693
   PubMed Web of Science ®Google Scholar
• PoordadFMcConeJBaconBSPRINT-2 InvestigatorsBoceprevir for untreated chronic HCV genotype 1 infectionN Engl J Med20113641195120621449783
   PubMed Web of Science ®Google Scholar
• BaconBGordonSLawitzEHCV RESPOND-2 InvestigatorsBoceprevir for previously treated chronic HCV genotype 1 infectionN Engl J Med20113641207121721449784
   PubMed Web of Science ®Google Scholar
• FlammSLawitzEJacobsonIBoceprevir with peginterferon alfa-2a-ribavirin is effective for previously treated chronic hepatitis C genotype 1 infectionClin Gastroenterol Hepatol2013111818723064222
   PubMed Web of Science ®Google Scholar
• CooperCLesterRThorlundKDirect-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysisQJM2013106215316323159839
   PubMed Web of Science ®Google Scholar
• CooperCDruytsEThorlundKBoceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysisTher Clin Risk Manag2012810513022442631
   PubMed Web of Science ®Google Scholar
• CureSDielsJGavartSBianicFJonesEEfficacy of telaprevir and boceprevir in treatment-naive and treatment-experienced genotype 1 chronic hepatitis C patients: an indirect comparison using Bayesian network meta-analysisCurr Med Res Opin201228111841185623016967
   PubMed Web of Science ®Google Scholar
• KieranJSchmitzSO’LearyAThe relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1Clininical Infectious Diseases12013562228235
   Web of Science ®Google Scholar
• McHutchisonJLawitzEShiffmanMIDEAL Study teamPeginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infectionN Engl J Med200936158059319625712
   PubMed Web of Science ®Google Scholar
• DruytsEMillsENachegaJO’ReganCCooperCDifferences in clinical outcomes among hepatitis C genotype 1-infected patients treated with peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin: a meta-analysisClin Exp Gastroenterol20125112122427726
   PubMedGoogle Scholar
• HigginsJPTGreenSThe Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]The Cochrane Collaboration2011 Available from: http://www.cochranehandbook.orgAccessed May 6, 2013
   Google Scholar
• EisenbergMFilionKYavinDPharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trialsCMAJ2008179213514418625984
   PubMed Web of Science ®Google Scholar
• MillsEWuPLockhartIThorlundKPuhanMEbbertJComparisons of high dose and combination nicotine replacement therapy, varenicline and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysisAnn Med201244458859722860882
   PubMed Web of Science ®Google Scholar
• MillsEWuPSpurdenDEbbertJWilsonKEfficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysisHarm Reduct J200962519761618
   PubMed Web of Science ®Google Scholar
• WalterSChoice of effect measure for epidemiological dataJ Clinical Epidemiol200053993193911004419
   PubMed Web of Science ®Google Scholar